Abstract
AbstractThe efficacy of photodynamic therapy (PDT) depends on the subcellular localization of photosensitizers. Herein, we report a dual‐organelle‐targeted nanoparticle platform for enhanced PDT of cancer. By grafting 5‐aminolevulinic acid (ALA) to a Hf12‐based nanoscale metal‐organic layer (Hf‐MOL) via carboxylate coordination, ALA/Hf‐MOL enhanced ALA delivery and protoporphyrin IX (PpIX) synthesis in mitochondria, and trapped the Hf‐MOL comprising 5,15‐di‐p‐benzoatoporphyrin (DBP) photosensitizers in lysosomes. Light irradiation at 630 nm simultaneously excited PpIX and DBP to generate singlet oxygen and rapidly damage both mitochondria and lysosomes, leading to synergistic enhancement of the PDT efficacy. The dual‐organelle‐targeted ALA/Hf‐MOL outperformed Hf‐MOL in preclinical PDT studies, with a 2.7‐fold lower half maximal inhibitory concentration in cytotoxicity assays in vitro and a 3‐fold higher cure rate in a colon cancer model in vivo.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
